14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 1.733 5 days ( -9.01 % )
Last Price $2.54 0 %
High/ Low $2.42 - $2.55 16.12%
Chg 7 Days 17.05 % $2.17 $2.54
Chg 30 Days 21.53 % $2.09 $2.54
Chg 12 mos 10.43 % $2.30 $2.54
Trend - 3 mos 6.20 % Width: 69.24 %
Trend - 12 mos -19.71 % Width: 239.87 %
Pred. range - 3 mos $2.02 - $3.41 -20.66 % - 34.28 %
Pred. range - 12 mos $0.748 - $2.54 -70.55 % - 0.0802 %
Short MA avg 3 mos Buy Apr 30, 2024 - 6 days
Long MA avg 3 mos Buy Apr 26, 2024 - 8 days
Short/Long MA avg 3 mos Buy Apr 11, 2024 - 19 days
Short MA avg 12 mos Buy May 01, 2024 - 5 days
Long MA avg 12 mos Buy Mar 27, 2024 - 29 days
Short/Long MA avg 12 mos Buy Dec 21, 2023 - 94 days
Pivot Short Sell Mar 01, 2024 - 47 days
Bollinger Buy Feb 01, 2024 - 67 days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Lyell Immunopharma, Inc.

Lyell Immunopharma. Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate population of T cells with durable stemness. Its pipeline includes LYL797, a T cell product candidate ... LYEL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT